-
Je něco špatně v tomto záznamu ?
Sustained Inflammatory Signalling through Stat1/Stat2/IRF9 Is Associated with Amoeboid Phenotype of Melanoma Cells
A. Gandalovičová, AM. Šůchová, V. Čermák, L. Merta, D. Rösel, J. Brábek,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
18-15684J
Grantová Agentura České Republiky
NLK
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
32872349
DOI
10.3390/cancers12092450
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
The invasive behaviour of cancer cells underlies metastatic dissemination; however, due to the large plasticity of invasion modes, it is challenging to target. It is now widely accepted that various secreted cytokines modulate the tumour microenvironment and pro-inflammatory signalling can promote tumour progression. Here, we report that cells after mesenchymal-amoeboid transition show the increased expression of genes associated with the type I interferon response. Moreover, the sustained activation of type I interferon signalling in response to IFNβ mediated by the Stat1/Stat2/IRF9 complex enhances the round amoeboid phenotype in melanoma cells, whereas its downregulation by various approaches promotes the mesenchymal invasive phenotype. Overall, we demonstrate that interferon signalling is associated with the amoeboid phenotype of cancer cells and suggest a novel role of IFNβ in promoting cancer invasion plasticity, aside from its known role as a tumour suppressor.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20021740
- 003
- CZ-PrNML
- 005
- 20201204092700.0
- 007
- ta
- 008
- 201125s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cancers12092450 $2 doi
- 035 __
- $a (PubMed)32872349
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Gandalovičová, Aneta $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
- 245 10
- $a Sustained Inflammatory Signalling through Stat1/Stat2/IRF9 Is Associated with Amoeboid Phenotype of Melanoma Cells / $c A. Gandalovičová, AM. Šůchová, V. Čermák, L. Merta, D. Rösel, J. Brábek,
- 520 9_
- $a The invasive behaviour of cancer cells underlies metastatic dissemination; however, due to the large plasticity of invasion modes, it is challenging to target. It is now widely accepted that various secreted cytokines modulate the tumour microenvironment and pro-inflammatory signalling can promote tumour progression. Here, we report that cells after mesenchymal-amoeboid transition show the increased expression of genes associated with the type I interferon response. Moreover, the sustained activation of type I interferon signalling in response to IFNβ mediated by the Stat1/Stat2/IRF9 complex enhances the round amoeboid phenotype in melanoma cells, whereas its downregulation by various approaches promotes the mesenchymal invasive phenotype. Overall, we demonstrate that interferon signalling is associated with the amoeboid phenotype of cancer cells and suggest a novel role of IFNβ in promoting cancer invasion plasticity, aside from its known role as a tumour suppressor.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šůchová, Anna-Marie $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
- 700 1_
- $a Čermák, Vladimír $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
- 700 1_
- $a Merta, Ladislav $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
- 700 1_
- $a Rösel, Daniel $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
- 700 1_
- $a Brábek, Jan $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
- 773 0_
- $w MED00173178 $t Cancers $x 2072-6694 $g Roč. 12, č. 9 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32872349 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201204092658 $b ABA008
- 999 __
- $a ind $b bmc $g 1591449 $s 1112412
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 12 $c 9 $e 20200828 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
- GRA __
- $a 18-15684J $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20201125